NCT04062591View on ClinicalTrials.gov

Efficacy of Piroxicam as a Perioperative Analgesic for Patients Undergoing Fixation of Maxillofacial Fractures

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

August 16, 2019

Primary Completion Date

April 30, 2022

Study Completion Date

December 31, 2022

Conditions
Postoperative Pain
Interventions
DRUG

Piroxicam group

patients will receive 0.4 mg/kg piroxicam IM

DRUG

Placebo

saline IM in the same dose of piroxicam

Trial Locations (1)

11566

Ain Shams U, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04062591 - Efficacy of Piroxicam as a Perioperative Analgesic for Patients Undergoing Fixation of Maxillofacial Fractures | Biotech Hunter | Biotech Hunter